 |
| The joint statement said that "people who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider". (Photo by= Reuters) |
[Asia News Communication = Reporter Reakkana] US health authorities call to postpone the use of the Johnson & Johnson Covid-19 vaccine, following reports of extremely rare blood clotting cases, BBC said.
The Food and Drug Administration (FDA) said it’s acting "out of an abundance of caution". It added that six cases of severe blood clotting had been detected in more than 6.8 million doses of the vaccine. The recommendation follows similar rare cases in the AstraZeneca vaccine, which has prompted some curbs in its use. In a series of tweets, the FDA said it and the Centers for Disease Control and Prevention (CDC) were reviewing "six reported US cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare". This was to "ensure that the health care provider community is aware of the potential for these adverse events".
A joint statement from the FDA and CDC clarified that the blood clotting was cerebral venous sinus thrombosis (CVST). Johnson & Johnson, a US health care company, issued a statement saying that safety was its "number one priority" and that it shared "all adverse event reports" with the health authorities.
